Thyrocare Technologies Limited — Investor Meet, 29-04-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Thyrocare Technologies Limited held an earnings conference call to discuss its performance for Q4 and the entire fiscal year. The company reported consolidated revenue of INR 687 crores, a 20% year-on-year growth, with Q4 revenue rising by 21%. The pathology segment grew 21%, and partnership revenue increased by 27%. Gross margin reached 74% in Q4 due to effective cost management and higher test volumes. Management remains confident in achieving mid-teen growth rates, emphasizing continuous investments in quality and network expansion. Overall sentiment appears positive.